156 related articles for article (PubMed ID: 38426619)
1. Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high-risk factors in locally advanced oral squamous cell carcinoma.
Kamal MV; Damerla RR; Parida P; Rao M; Belle VS; Dikhit PS; Palod A; Gireesh R; Kumar NA
Cancer Med; 2024 Feb; 13(3):e6986. PubMed ID: 38426619
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma.
Kamal MV; Damerla RR; Dikhit PS; Kumar NA
J Oral Biol Craniofac Res; 2023; 13(5):567-574. PubMed ID: 37559688
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation of CD3 & vascular endothelial growth factor in incisional oral squamous cell carcinoma biopsies predicts nodal metastasis & poor survival of patients.
Khan W; Augustine D; Rao RS
Indian J Med Res; 2023 May; 157(5):438-446. PubMed ID: 37322630
[TBL] [Abstract][Full Text] [Related]
4. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
5. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
[TBL] [Abstract][Full Text] [Related]
6. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
[TBL] [Abstract][Full Text] [Related]
7. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor.
Yu XH; Wu JB; Fan HY; Dai L; Xian HC; Chen BJ; Liao P; Huang MC; Pang X; Zhang M; Liang XH; Tang YL
Oral Dis; 2024 Mar; 30(2):363-375. PubMed ID: 36321394
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA XIST promotes the malignant features of oral squamous cell carcinoma (OSCC) cells through regulating miR-133a-5p/VEGFB.
Wu K; Wu W; Wu M; Liu W
Histol Histopathol; 2023 Jan; 38(1):113-126. PubMed ID: 35912960
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
Guo ZC; Jing SL; Jumatai S; Gong ZC
Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
[TBL] [Abstract][Full Text] [Related]
11. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
12. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
13. Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma.
Pandey A; Bhuvanadas S; Joseph JP; Jayaraj R; Devi A
Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2159-2168. PubMed ID: 33882814
[TBL] [Abstract][Full Text] [Related]
14. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786
[TBL] [Abstract][Full Text] [Related]
15. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G
Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
Shen Y; Xu Z; Liu M; Piao S; Li J
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
[TBL] [Abstract][Full Text] [Related]
17. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
[TBL] [Abstract][Full Text] [Related]
18. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
19. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
20. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.
Giatromanolaki A; Koukourakis MI; Sivridis E; Thorpe PE; Brekken RA; Konstantinos S; Fountzilas G; Gatter KC; Harris AL
Clin Exp Metastasis; 2000; 18(4):313-9. PubMed ID: 11448062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
